爱康召开媒体说明会公开回应体检争议：无责，以医学事实厘清责任

Core Viewpoint - Aikang Group held a media briefing to address the incident involving Ms. Zhang, who claimed that her kidney cancer was not detected during ten years of health check-ups. The company asserts that there were no diagnostic errors or "fake health checks" in Ms. Zhang's case and has filed a lawsuit against her for defamation [1][3][18]. Group 1: Company Response - Aikang Group confirmed that there were no missed or misdiagnosed issues in Ms. Zhang's kidney examinations, and the findings in her health report were consistent with the actual ultrasound results [6][8]. - The company emphasized that health check-ups are not equivalent to clinical diagnoses and are designed to help individuals identify potential health issues, which should then be followed up with specialized medical consultations [3][16]. - Aikang Group's CEO expressed sympathy for Ms. Zhang's condition but criticized her for spreading false information that could damage the reputation of the company and the healthcare industry [16][18]. Group 2: Medical and Technical Clarifications - The ultrasound report from Ms. Zhang's examination indicated potential issues, including a left kidney hamartoma and a calcification in the right kidney, with recommendations for further diagnostic procedures [6][9]. - Aikang Group's medical experts clarified that the cancer embryonic antigen (CEA) test is not relevant for kidney cancer screening, as early diagnosis primarily relies on imaging techniques rather than blood tests [13][15]. - The company provided evidence of quality control in its testing processes and stated that all medical personnel are certified and that equipment meets national standards [9][10].